Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population

Diabetes and Metabolism

Volumn 34, Issue 3, 2008, Pages 273-278

  Kifagi, C ^a   Makni, K ^a   Mnif, F ^b   Boudawara, M ^c   Hamza, N ^c   Rekik, N ^b   Abid, M ^b   Rebai A ^a   Granier, C ^d   Jarraya, F ^a,b   Ayadi, H ^a  

^a CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c Laboratory of Analyses   (Tunisia)

^d CNRS FRE3009 SysDiag   (France)

Author keywords

Association; Calpain; Genetics; Haplotype combination; SNP; Type 2 diabetes mellitus

Indexed keywords

CALPAIN 10; PROTEINASE;

ADULT; ALLELE; ARTICLE; CHROMOSOME 2Q; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IMMUNIZATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

AGED; CALPAIN; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REFERENCE VALUES; TUNISIA;

EID: 49849085003     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.01.007     Document Type: Article

References (30)

1. Kahn C.R. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43 (1994) 1066-1082
2. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., et al. Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329 (1993) 1988-1992
3. Newman B., Selby J.V., King M.C., Slemenda C., Fabsitz R., and Friedman G.D. Concordance for type 2 (noninsulin-dependent) diabetes mellitus in male twins. Diabetologia 30 (1987) 763-768
4. Hanis C.L., Boerwinkle E., Chakraborty R., Ellsworth D.L., Concannon P., and Stirling B. A genome-wide search for human noninsulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13 (1996) 161-166
5. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., and Hara M. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26 (2000) 163-175
6. Schwarz P.E.H., Horikawa Y., Vcelak J., Selisko T., Rietzsch H., Bendlova B., et al. Genetic variation of CAPN10 affects susceptibility to type 2 diabetes in German and Czech populations. Diabetes 50 Suppl. 2 (2001) SA232 [abstract]
7. Rasmussen S.K., Urhammer S.A., Berglund L., Jensen J.N., Hansen L., Echwald S.M., et al. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51 (2002) 3561-3567
8. 2+ binding domain. J Biol Chem 268 (1993) 19476-19482
9. Orho-Melander M., Klannemark M., Svensson M.K., Ridderstrale M., Lindgren C.M., and Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51 (2002) 2658-2664
10. Smith L., Rice K., and Garner C. The insulin induced down regulation of IRS1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease. Mol Cell Endocrinol 122 (1996) 81-92
11. Paul D.S., Harmoun A.W., Winston C.P., and Patel Y.M. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J 376 (2003) 625-632
12. Marshall C., Hitman G.A., Partridge C.J., Clark A., Ma H., Shearer T.R., et al. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol 19 (2004) 213-224
13. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
14. Kang E.S., Nam M., Kim H.J., Myoung S.M., and Rhee Y. Haplotype combination of calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract 73 (2006) 268-275
15. Evans J.C., Frayling T.M., Cassell P.G., Saker P.J., Hitman R.A., Walker M., et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69 (2001) 544-552
16. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1995) 251-253
17. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
18. Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
19. Ng M.C.Y., So W.Y., Critchley J.A.J.H., Cockram C.S., and Chan J.C.N. Association of calpain-10 genetic polymorphisms with type 2 diabetes and insulin response in non-diabetic Chinese. Diabetes 50 Suppl. 2 (2001) SA234 [Abstract]
20. Fullerton S.M., Bartoszewicz A., Ybazeta G., Horikawa Y., Bell G.I., Kidd K.K., et al. Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am J Hum Genet 70 (2002) 1096-1106
21. Song Y., Niu T., Manson J.E., Kwiatkowski D.J., and Simin. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 74 (2004) 208-222
22. Fingerlin T.E., Erdos M.R., Watanabe R.M., Wiles K.R., Stringham H.M., Mohlke K.L., et al. Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes 51 (2002) 1644-1648
23. Horikawa Y., Oda N., Yu L., Imamura S., Fujiwara K., Makino M., et al. Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J Clin Endocrinol Metab 88 (2003) 244-247
24. Daimon M., Oizumi T., Saitoh T., Kameda W., Yamaguchi H., Ohnuma H., et al. Calpain-10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 56 (2002) 147-152
25. Xiang K., Zheng T., Fang Q., Jia W., Wang Y., Zhang R., et al. Calpain-10 SNP43 polymorphism is associated with insulin sensitivity and insulin levels during glucose load in Chinese non-diabetic subjects. Diabetes 50 Suppl. 2 (2001) SA232 [abstract]
26. Hegele R.A., Harris S.B., Zinman B., Hanley A.J., and Cao H. Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 24 (2001) 1498-1499
27. Chen Y., Kittles R., Zhou J., Chen G., Adeyemo A., Panguluri R.K., et al. Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America diabetes mellitus (AADM) study. Ann Epidemiol 15 (2005) 153-159
28. Pihlajamäki J., Salmenniemi U., Vänttinen M., Ruotsalainen E., Kuusisto J., Vauhkonen I., et al. Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes. Diabetologia 49 (2006) 1560-1566
29. Song Y., Niu T., Manson J.E., Kwiatkowski D.J., and Liu S. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 74 (2004) 208-222
30. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309